1. The involvement of endothelin in the renal responses to radiocontra
st media was examined in the rat in vitro and in vivo using BQ123, a s
elective endothelin (ET(A)) receptor antagonist, and phosphoramidon, a
n endothelin-converting enzyme inhibitor. 2. For experiments in vitro,
an isolated perfused rat kidney was employed perfusing in closed circ
uit with an albumin-based Krebs-Henseleit solution. The effects of BQ1
23 and phosphoramidon on the renal responses to iotrolan (iso-osmolar
radiocontrast media) and diatrizoate (high-osmolar radiocontrast media
) were examined. In vivo, renal conductance was measured using a Doppl
er flow probe in the anaesthetized rat pretreated with indomethacin, a
nd the effects of BQ123 and phosphoramidon on the renal response to in
travenous diatrizoate were examined. 3. In vitro, iotrolan and diatriz
oate both produced a biphasic effect on the glomerular filtration rate
, characterized by a transient increase followed by a sustained fall.
Pretreatment with BQ123 (10 mu mol/l), but not phosphoramidon (1 mmol/
l), prevented both the increase and the sustained fall in glomerular f
iltration rate induced by radiocontrast media. 4. In vitro, iotrolan a
nd diatrizoate both produced a sustained fall in renal perfusate flow.
An initial increase in renal perfusate flow was only observed with di
atrizoate. Pretreatment with BQ123 (10 mu mol/l), but not with phospho
ramidon (1 mmol/l), markedly inhibited the sustained fall in renal per
fusate flow produced by both iotrolan and diatrizoate. BQ123 (10 mu mo
l/l), however, markedly potentiated the renal vasodilatation produced
by diatrizoate. 5. In vivo, in the anaesthetized rat treated with indo
methacin, the sustained fall in renal conductance produced by diatrizo
ate (2.9 g of iodine/kg, intravenously) was markedly inhibited by pret
reatment with BQ123 (1 mg/kg) but not with phosphoramidon (10 mg/kg).
6. A role for endothelin as a mediator of the renal responses of radio
contrast media is proposed.